Availability of information for dosing injectable medications in underweight or obese patients

Author:

Jacques Kimberly A.1,Erstad Brian L.2

Affiliation:

1. Veterans Affairs Sierra Nevada Health Care System, Reno, NV

2. Brian L. Erstad, Department of Pharmacy Practice and Science, College of Pharmacy—Pulido Center, University of Arizona, Tucson

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Reference10 articles.

1. World Health Organization. Global database on body mass index. www.who.int/bmi/index.jsp?introPage=intro_3.html (accessed 2009 Mar 4).

2. What is the best size descriptor to use for pharmacokinetic studies in the obese?;Green;Br J Clin Pharmacol,2004

3. National Center for Health Statistics. Prevalence of overweight among children and adolescents. www.cdc.gov/nchs/products/pubs/pubd/hestats/overweight/overweight_child_03.htm (accessed 2009 Mar 6).

4. Drugs.com. New drug approvals. www.drugs.com/newdrugs.html (accessed 2009 Mar 4).

5. U.S. Food and Drug Administration. New drug approvals. www.fda.gov/Drugs/NewsEvents/UCM130961 (accessed 2009 Mar 4).

Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3